Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Specialty Palliative Care in Pediatric Oncology: A Systematic Review.
Kaye EC, Weaver MS, DeWitt LH, Byers E, Stevens SE, Lukowski J, Shih B, Zalud K, Applegarth J, Wong HN, Baker JN, Ullrich CK; AAHPM Research Committee. Kaye EC, et al. Among authors: stevens se. J Pain Symptom Manage. 2021 May;61(5):1060-1079.e2. doi: 10.1016/j.jpainsymman.2020.12.003. Epub 2020 Dec 24. J Pain Symptom Manage. 2021. PMID: 33348034 Free PMC article.
Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
Ullrich CK, Baker KK, Carpenter PA, Flowers ME, Gooley T, Stevens S, Krakow EF, Oshima MU, Salit RB, Vo P, Connelly-Smith L, Lee SJ, Wood WA. Ullrich CK, et al. Transplant Cell Ther. 2023 Mar;29(3):200.e1-200.e8. doi: 10.1016/j.jtct.2022.11.030. Epub 2022 Dec 6. Transplant Cell Ther. 2023. PMID: 36494015 Free article.
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor.
Dagogo-Jack I, Moonsamy P, Gainor JF, Lennerz JK, Piotrowska Z, Lin JJ, Lennes IT, Sequist LV, Shaw AT, Goodwin K, Stevens SE, Do A, Digumarthy SR, Price K, Muzikansky A, Hata AN, Heist RS. Dagogo-Jack I, et al. Among authors: stevens se. J Thorac Oncol. 2021 May;16(5):850-859. doi: 10.1016/j.jtho.2021.01.1605. Epub 2021 Feb 3. J Thorac Oncol. 2021. PMID: 33545388 Free PMC article. Clinical Trial.
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer.
Dagogo-Jack I, Yoda S, Lennerz JK, Langenbucher A, Lin JJ, Rooney MM, Prutisto-Chang K, Oh A, Adams NA, Yeap BY, Chin E, Do A, Marble HD, Stevens SE, Digumarthy SR, Saxena A, Nagy RJ, Benes CH, Azzoli CG, Lawrence MS, Gainor JF, Shaw AT, Hata AN. Dagogo-Jack I, et al. Among authors: stevens se. Clin Cancer Res. 2020 Jun 1;26(11):2535-2545. doi: 10.1158/1078-0432.CCR-19-3906. Epub 2020 Feb 21. Clin Cancer Res. 2020. PMID: 32086345 Free PMC article.
87 results